eISSN: 3023-6940
  • Home
  • At what stage are we in active surveillance for localized prostate cancer? Our clinical experience
E-SUBMISSION

Original Research

At what stage are we in active surveillance for localized prostate cancer? Our clinical experience


University of Health Sciences Bakırköy Dr. Sadi Konuk Training and Research Hospital, Department of Urology, İstanbul, Turkey


DOI : 10.33719/yud.2023;18-1-1129666
New J Urol. 2023;18(1):8-15

Abstract

The incidence of developing testicular cancer is % 0.2 during the entire life span.  90-95% of testiculer tumors stem from ger-minal tissue. The testicular germ cell tumors are classified as pure seminoma germ cell tumors and nonseminomatous germ cell tu-mors. The incidence rate of bilateral is 1-4%. Seminoma is the most common germ cell tumor among bilateral testicular cancer. But the most common bilateral tumor is malig-nant lymphoma. Today radical orchiectomy is considered standart therapy for testiculer tumors. We presented a case with metachro-nous testiculer tumor whose first pathologic evaluation was reported as seminoma and se-cond one was reported as nonseminomatous germ cell tumor.

Keywords: testicular tumor, bilateral, metachron


Abstract

The incidence of developing testicular cancer is % 0.2 during the entire life span.  90-95% of testiculer tumors stem from ger-minal tissue. The testicular germ cell tumors are classified as pure seminoma germ cell tumors and nonseminomatous germ cell tu-mors. The incidence rate of bilateral is 1-4%. Seminoma is the most common germ cell tumor among bilateral testicular cancer. But the most common bilateral tumor is malig-nant lymphoma. Today radical orchiectomy is considered standart therapy for testiculer tumors. We presented a case with metachro-nous testiculer tumor whose first pathologic evaluation was reported as seminoma and se-cond one was reported as nonseminomatous germ cell tumor.

Keywords: testicular tumor, bilateral, metachron